WebInstitutional Ownership and Shareholders. Viking Therapeutics Inc (US:VKTX) has 187 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27,729,604 shares. Largest shareholders include Vanguard Group Inc, Millennium Management Llc, Balyasny ... Web1 day ago · 4D Molecular Therapeutics, Inc.: SVB Securities LLC Neut.. 4D Molecular Therapeutics annuncia l'approvazione da parte della FDA della domanda IND .. 4D Molecular Therapeutics, Inc.: BMO Capital è per il Bu.. 4D Molecular Therapeutics, Inc. annuncia aggiornamenti sulla pipeline clinica e su ulte..

Viking Therapeutics Inc (VKTX) Stock Price Today, News, Quotes, …

Web12 hours ago · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... WebMarket Cap. $1.7B. Currency in USD. Quote data delayed by at least 15 minutes. sandfish publishing

VKTX - Viking Therapeutics, Inc. Stock Price and Quote - FINVIZ.com

WebApr 3, 2024 · SAN DIEGO, April 3, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ... WebApr 10, 2024 · On Monday 04/10/2024 the closing price of the Viking Therapeutics Inc share was $16.94 on NAS. Compared to the opening price on Monday 04/10/2024 on NAS of … WebOct 2, 2015 · Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced... shop titans cheat codes